| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
1 company
Jones Randal is a 10% Owner at AVTX. Recent filings cover 0 purchases and 1 sale. Those positions are worth an estimated $4K at current prices.
Jones Randal's largest disclosed position is in AVTX as 10% Owner, worth about $4K. The recent filings there lean toward selling, a net 1,270 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 13, 2018 | AVTX Avalo Therapeutics, Inc. | 10% Owner | Sale+OE | 1,270 | $3.98 | $5,054.60 | -100% |